Atlas FDA

GEL-ONE(R)

FDA premarket approval P080020/S020 · decided 2016-09-27

Approval details

PMA number
P080020
Supplement
S020
Supplement type
Panel Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
GEL-ONE(R)
Generic name
Acid, hyaluronic, intraarticular
Applicant
Seikagaku Corp.
Date received
2016-04-01
Decision date
2016-09-27
Days to decision
179 days
Decision code
APPR
Product code
MOZ
Advisory committee
Orthopedic
Expedited review
No
Location
Tokyo
Statement
Approval for Gel-One. The device is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to non-pharmacologic therapy, non-steroidal anti-inflammatory drugs (NSAIDs) or analgesics, e.g., acetaminophen.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
HADGEL, 4 GRAM/SYRINGE (K011544)Seikagaku Corp.2001-08-15